Cleared Special

Millipede 088 Access Catheter (K231802) - FDA 510(k) Clearance

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K231802 · Perfuze, Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
91d
Days
Class 2
Risk

K231802 is an FDA 510(k) clearance for the Millipede 088 Access Catheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Perfuze, Ltd. (Dangan, IE). The FDA issued a Cleared decision on September 19, 2023 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Perfuze, Ltd. devices

Submission Details

510(k) Number K231802 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2023
Decision Date September 19, 2023
Days to Decision 91 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 148d · This submission: 91d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K231802.
Radical the Dude 7F Guide Catheter
K231393 · Maduro Medical, Inc. · Nov 2023
CEREGLIDE 92 Intermediate Catheter
K230726 · Cerenovus, Inc. · Nov 2023
Q Distal Access Catheter
K222948 · Mivi Neuroscience, Inc. · Sep 2023
SOFIA EX Intracranial Support Catheter
K230775 · MicroVention, Inc. · Sep 2023
NG Delivery Catheter
K230609 · Balt USA, LLC · Sep 2023
Plato 17 Microcatheter
K223560 · Scientia Vascular, Inc. · Aug 2023